Welcome to BioRN

About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant  part in this development.

With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”

News

July 29, 2014
Merck Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
» [more]

July 28, 2014
A protein couple controls flow of information into the brain’s memory center
» [more]

July 24, 2014
Merck Serono Announces Collaboration with San Raffaele University & Research Hospital for Research in Neurodegenerative Diseases
» [more]

Newsletter

Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.

Events

» Find further future events here

HAE R&D Community

Increase your chances of getting your R&D project funded